CERUS CORP (CERS) research
CERUS CORP- Sector
- Health Care
- Last price
- $2.65
- As of
CERUS CORP (CERS): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-30.
As of . Source: SEC EDGAR filings for CERS. Method and limitations.
Share the CERS intelligence card
See CERS live in the terminal
Track CERS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live CERS terminal, freeActive signals for CERS
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +873% to CERS (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 75% of CERS (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +147% to CERS (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +2246% to CERS (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +873% to CERS (2026Q2)
FREE, NO ACCOUNT
Every signal on CERS, as it fires
You are seeing 5 of 20 signals recorded on CERS since 2026-05-24.
The five above all landed on 2026-09-06. The other 15 were recorded on 4 other days. 15 of the 20 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CERS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 157085101 · 2026Q2 | $16M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 157085101 · 2026Q2 | $10.2M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 157085101 · 2026Q2 | $2.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 157085101 · 2026Q2 | $2M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 157085101 · 2026Q2 | $666K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 157085101 · 2026Q2 | $317K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CERS
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CERS against its peers
CERS's operating margin of -3.7% ranks in the 55th percentile of 20 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | CERS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 234M USD | 333M USD | 26 | 20 |
| Gross margin | n/a | 66.0% | n/a | 10 |
| Operating margin | -3.7% | -9.2% | 55 | 20 |
| Net margin | -6.7% | -8.7% | 64 | 20 |
| Return on equity | -24.3% | -14.1% | 28 | 19 |
Peers (20): CTEV, FLGT, SGHT, ANGO, CCRN, EVH, EHAB, AHCO, SLP, VREX, HSTM, TALK, BVS, RXST, STAA, IRMD, CSTL, PRCT, GDRX, TDOC. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (CERS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more CERS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CERSand get the insider, 13F, options, and confluence read in one view.